[1]. [Clinical feature of 23 cases of combined influenza virus and bacterial pneumonia].
Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society [巻]45 [号]9 [頁]667 -72 （2007年） [査読] 有
[2]. [A case of antiphospholipid syndrome associated with acute respiratory distress syndrome].
Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society [巻]46 [号]11 [頁]955 -9 （2008年） [査読] 有
[3]. Drug lymphocyte stimulation test in the diagnosis of adverse reactions to antituberculosis drugs.
Chest [巻]134 [号]5 [頁]1027 -1032 （2008年） [査読] 有
[DOI] [4]. Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis.
Lung [巻]187 [号]3 [頁]201 -6 （2009年） [査読] 有
[DOI] [5]. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.
Lung cancer (Amsterdam, Netherlands) [巻]67 [号]3 [頁]361 -5 （2010年） [査読] 有
[DOI] [6]. Serum activity of indoleamine 2,3-dioxygenase predicts prognosis of community-acquired pneumonia.
The Journal of infection [巻]63 [号]3 [頁]215 -22 （2011年） [査読] 有
[DOI] [7]. Serum indoleamine 2,3-dioxygenase activity predicts prognosis of pulmonary tuberculosis.
Clinical and vaccine immunology : CVI [巻]19 [号]3 [頁]436 -42 （2012年） [査読] 有
[DOI] [8]. Indoleamine 2,3-dioxygenase in the pathogenesis of tuberculous pleurisy
[巻]17 [号]11 [頁]1501 -1506 （2013年） [査読] 有
[9]. Mouse CD11bhigh lung dendritic cells have more potent capability to induce IgA than CD103+ lung dendritic cells in vitro.
American journal of respiratory cell and molecular biology [巻]46 [号]6 [頁]773 -80 （2012年） [査読] 有
[DOI] [10]. Diffuse alveolar hemorrhage caused by exposure to organic dust.
Respiratory medicine case reports [巻]15 [頁]59 -61 （2015年） [査読] 有
[DOI] [11]. Cumulative incidence of tuberculosis in lung cancer patients in Japan: A 6-year observational study.
Respiratory investigation [巻]54 [号]3 [頁]179 -83 （2016年） [査読] 有
[DOI] [12]. Morphological changes in small pulmonary vessels are associated with severe acute exacerbation in chronic obstructive pulmonary disease.
International journal of chronic obstructive pulmonary disease [巻]11 [頁]1435 -45 （2016年） [査読] 有
[DOI] [13]. Soluble hemoglobin scavenger receptor CD163 (sCD163) predicts mortality of community-acquired pneumonia.
The Journal of infection [巻]73 [号]4 [頁]375 -7 （2016年） [査読] 有
[DOI] [14]. Utility of Macrophage-activated Marker CD163 for Diagnosis and Prognosis in Pulmonary Tuberculosis.
Annals of the American Thoracic Society [巻]14 [号]1 [頁]57 -64 （2017年） [査読] 有
[DOI] [15]. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
Arthritis research & therapy [巻]19 [号]1 [頁]9 （2017年） [査読] 有
[DOI] [16]. Persistent impairment on spirometry in chronic eosinophilic pneumonia: A longitudinal observation study (Shizuoka-CEP study).
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [巻]119 [号]5 [頁]422 -428.e2 （2017年） [査読] 有
[DOI] [17]. Utility of serum Aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease.
PloS one [巻]13 [号]6 [頁]e0198479 （2018年） [査読] 有
[DOI] [18]. Long-term management and persistent impairment of pulmonary function in chronic eosinophilic pneumonia: A review of the previous literature.
Allergology international : official journal of the Japanese Society of Allergology [巻]67 [号]3 [頁]334 -340 （2018年） [査読] 有
[DOI] [19]. Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis.
Scientific reports [巻]8 [号]1 [頁]13129 （2018年） [査読] 有
[DOI] [20]. Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis.
Scientific reports [巻]8 [号]1 [頁]14074 （2018年） [査読] 有
[DOI] [21]. Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD.
Rheumatology (Oxford, England) [巻]58 [号]12 [頁]2143 -2152 （2019年） [査読] 有
[DOI] [22]. Eosinophilic pneumonia: A review of the previous literature, causes, diagnosis, and management.
Allergology international : official journal of the Japanese Society of Allergology [巻]68 [号]4 [頁]413 -419 （2019年） [査読] 有
[DOI] [23]. Body composition changes successfully classify prognosis in patients with mycobacterium avium complex lung disease.
The Journal of infection [巻]79 [号]4 [頁]341 -348 （2019年） [査読] 有
[DOI] [24]. Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD.
International journal of chronic obstructive pulmonary disease [巻]14 [頁]1867 -1877 （2019年） [査読] 有
[DOI] [25]. Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia.
Scientific reports [巻]9 [号]1 [頁]18750 （2019年） [査読] 有
[DOI] [26]. Imaging mass spectrometry to visualise increased acetylcholine in lungs of asthma model mice.
Analytical and bioanalytical chemistry [巻]412 [号]18 [頁]4327 -4341 （2020年） [査読] 有
[DOI] [27]. CD200 and CD200R1 expressions and their prognostic roles in patients with non-small cell lung cancer
Oncoimmunology [巻]78 [号]13 （2020年） [査読] 有
[DOI] [28]. Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis.
Respiratory medicine [巻]171 [頁]106078 （2020年） [査読] 有
[DOI] [機関リポジトリ][29]. Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy.
Respirology (Carlton, Vic.) [巻]26 [号]2 [頁]171 -179 （2021年） [査読] 有
[DOI] [機関リポジトリ][30]. Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study.
BMC pulmonary medicine [巻]21 [号]1 [頁]221 （2021年） [査読] 有
[DOI] [31]. Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study.
Respiratory research [巻]23 [号]1 [頁]79 （2022年） [査読] 有
[DOI] [32]. Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis.
Respiratory research [巻]23 [号]1 [頁]142 （2022年） [査読] 有
[DOI] [33]. Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physicians.
Respiratory investigation [巻]60 [号]6 [頁]779 -786 （2022年） [査読] 有
[DOI] [34]. Treatments of refractory eosinophilic lung diseases with biologics.
Allergology international : official journal of the Japanese Society of Allergology [巻]72 [号]1 [頁]31 -40 （2023年） [査読] 有
[DOI] [35]. Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis
RESPIROLOGY [巻]28 [号]8 [頁]775 -783 （2023年） [査読] 有
[DOI] [36]. Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis.
Scientific reports [巻]11 [号]1 [頁]18579 （2021年） [査読] 有
[DOI] [37]. Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosis.
ERJ open research [巻]9 [号]3 （2023年） [査読] 有
[DOI] [38]. Neutrophil-lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis
BMJ OPEN RESPIRATORY RESEARCH [巻]10 [号]1 （2023年） [査読] 有
[DOI] [39]. Neutrophil-lymphocyte ratio being associated with mortality risk in patients receiving antifibrotic therapy.
Respiratory medicine [巻]223 [頁]107542 （2024年） [査読] 有
[DOI] [40]. Prognostic value of CT assessment of normal lung volume in upper-lobe in idiopathic pleuroparenchymal fibroelastosis
ERJ Open Research （2024年） [査読] 有
[DOI] [41]. ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity.
Immunity [巻]42 [号]3 [頁]538 -51 （2015年） [査読] 有
[DOI] [42]. Methotrexate-associated Lymphoproliferative Disorder with Diffuse Ground-Glass Opacities.
American journal of respiratory and critical care medicine [巻]199 [号]8 [頁]1031 -1033 （2019年） [査読] 有
[DOI] [43]. Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis.
Thorax （2022年） [査読] 有
[DOI] [機関リポジトリ][44]. Quality of dying and death in patients with interstitial lung disease compared with lung cancer: an observational study.
Thorax [巻]76 [号]3 [頁]248 -255 （2021年） [査読] 有
[DOI] [45]. CD109 on Dendritic Cells Regulates Airway Hyperreactivity and Eosinophilic Airway Inflammation.
American journal of respiratory cell and molecular biology [巻]68 [号]2 [頁]201 -212 （2023年） [査読] 有
[DOI] [46]. CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β Signaling.
Journal of immunology (Baltimore, Md. : 1950) [巻]212 [号]7 [頁]1221 -1231 （2024年） [査読] 有
[DOI] [47]. Idiopathic pleuroparenchymal fibroelastosis: three-dimensional computed tomography assessment of upper-lobe lung volume.
The European respiratory journal [巻]60 [号]6 （2022年） [査読] 有
[DOI] [48]. Assessment of Immune-Related Interstitial Lung Disease in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: A Multi-Center Prospective Study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [巻]15 [号]8 [頁]1317 -1327 （2020年） [査読] 有
[DOI] [機関リポジトリ][49]. Lack of autophagy induces steroid-resistant airway inflammation.
The Journal of allergy and clinical immunology [巻]137 [号]5 [頁]1382 -1389.e9 （2016年） [査読] 有
[DOI] [50]. Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity.
Nature communications [巻]7 [頁]13202 （2016年） [査読] 有
[DOI] [51]. Involvement of autophagy in exacerbation of eosinophilic airway inflammation in a murine model of obese asthma.
Autophagy [頁]1 -13 （2022年） [査読] 有
[DOI] [52]. Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study
RESPIRATORY RESEARCH [巻]25 [号]1 （2024年） [査読] 有
[DOI] [53]. CLEC10A expression defines functionally distinct subsets of conventional type 2 dendritic cells (cDC2) in the mouse lung.
Allergology international : official journal of the Japanese Society of Allergology （2024年） [査読] 有
[DOI] [54]. Prognostic Role of Interferon-λ3 in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Interstitial Lung Disease
ARTHRITIS & RHEUMATOLOGY （2024年） [査読] 有
[DOI] [機関リポジトリ][55]. Association of the lung immune prognostic index with the survival of patients with idiopathic interstitial pneumonias
RESPIROLOGY [巻]29 [号]2 [頁]136 -145 （2024年） [査読] 有
[DOI] [56]. Pan-cancer assessment of antineoplastic therapy-induced interstitial lung disease in patients receiving subsequent therapy immediately following immune checkpoint blockade therapy
RESPIRATORY RESEARCH [巻]25 [号]1 （2024年） [査読] 有
[DOI] [57]. "Bull's-eye" Sign and Its Longitudinal Change on High-Resolution Computed Tomography in Pulmonary Sarcoidosis.
American journal of respiratory and critical care medicine [巻]209 [号]1 [頁]e1-e3 （2024年） [査読] 有
[DOI] [58]. Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study.
Emerging microbes & infections [巻]12 [号]1 [頁]2155250 （2023年） [査読] 有
[DOI] [59]. Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy
CANCER IMMUNOLOGY IMMUNOTHERAPY [巻]72 [号]8 [頁]2717 -2728 （2023年） [査読] 有
[DOI] [60]. Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II study
JOURNAL FOR IMMUNOTHERAPY OF CANCER [巻]11 [号]7 （2023年） [査読] 有
[DOI] [61]. A predictive model for acute exacerbation of idiopathic interstitial pneumonias.
The European respiratory journal （2023年） [査読] 有
[DOI] [機関リポジトリ][62]. 間質性肺疾患患者におけるCOVID-19の死亡率:ナショナルデータベースを用いた大規模調査
日本呼吸器学会誌(Web) [巻]12 （2023年） [査読] 有
[63]. Association between increased peripheral blood CD86-positive plasmacytoid dendritic cells and immune-related adverse events in patients with non-small cell lung cancer.
Global health & medicine [巻]4 [号]6 [頁]301 -308 （2022年） [査読] 有
[DOI] [64]. Prognostic significance of radiological pleuroparenchymal fibroelastosis in complex lung disease: a multicentre retrospective cohort study.
Thorax （2022年） [査読] 有
[DOI] [65]. Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases.
BMC pulmonary medicine [巻]22 [号]1 [頁]387 （2022年） [査読] 有
[DOI] [66]. Effect of Hypoxia on Pulmonary Endothelial Cells from Bleomycin-Induced Pulmonary Fibrosis Model Mice.
International journal of molecular sciences [巻]23 [号]16 （2022年） [査読] 有
[DOI] [67]. Associations of serum long-chain fatty acids with multiple organ involvement in patients with sarcoidosis.
BMC pulmonary medicine [巻]22 [号]1 [頁]290 （2022年） [査読] 有
[DOI] [68]. Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer.
Journal of cancer research and clinical oncology （2022年） [査読] 有
[DOI] [69]. Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epithelium.
BMC pulmonary medicine [巻]22 [号]1 [頁]186 （2022年） [査読] 有
[DOI] [70]. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model.
Respiratory research [巻]23 [号]1 [頁]57 （2022年） [査読] 有
[DOI] [71]. Multiple organ infarction caused by aortic thrombus in a lung cancer patient with the mutation.
Respiratory medicine case reports [巻]36 [頁]101608 （2022年） [査読] 有
[DOI] [72]. Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non-Small Cell Lung Cancer After Nivolumab Therapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) [巻]45 [号]2 [頁]125 -131 （2022年） [査読] 有
[DOI] [73]. Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study.
Therapeutic advances in chronic disease [巻]13 [頁]20406223221108395 （2022年） [査読] 有
[DOI] [74]. Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case report.
Respiratory medicine case reports [巻]37 [頁]101632 （2022年） [査読] 有
[DOI] [75]. Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer.
Cancer immunology, immunotherapy : CII [巻]71 [号]1 [頁]203 -217 （2022年） [査読] 有
[DOI] [76]. Transient leukocytopenia following combination therapy for COVID-19.
Respiratory investigation [巻]60 [号]1 [頁]158 -161 （2022年） [査読] 有
[DOI] [77]. EGFR-Mutated Lung Adenocarcinoma Successfully Treated With Osimertinib After Spontaneous Transformation to SCLC and Adenocarcinoma With Neuroendocrine Differentiation: Case Report
JTO clinical and research reports [巻]3 [号]1 [頁]100264 （2022年） [査読] 有
[DOI] [78]. Marked, Lasting Disease Regression and Concomitantly Induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in a Patient With Lung Adenocarcinoma and Autoantibodies Receiving Atezolizumab Plus Chemotherapy: A Case Report.
JTO clinical and research reports [巻]3 [号]1 [頁]100263 （2022年） [査読] 有
[DOI] [79]. Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy.
BMC pulmonary medicine [巻]21 [号]1 [頁]409 （2021年） [査読] 有
[DOI] [80]. Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary Fibrosis.
Chest [巻]160 [号]6 [頁]2149 -2157 （2021年） [査読] 有
[DOI] [機関リポジトリ][81]. Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias.
Respiratory research [巻]22 [号]1 [頁]290 （2021年） [査読] 有
[DOI] [82]. Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis.
Respiratory investigation [巻]59 [号]6 [頁]827 -836 （2021年） [査読] 有
[DOI] [機関リポジトリ][83]. MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
JTO clinical and research reports [巻]2 [号]11 [頁]100239 （2021年） [査読] 有
[DOI] [84]. Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis.
BMC pulmonary medicine [巻]21 [号]1 [頁]309 （2021年） [査読] 有
[DOI] [85]. Diagnostic and prognostic significance of serum angiopoietin-1 and -2 concentrations in patients with pulmonary hypertension.
Scientific reports [巻]11 [号]1 [頁]15502 （2021年） [査読] 有
[DOI] [86]. Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas.
Scientific reports [巻]11 [号]1 [頁]14999 （2021年） [査読] 有
[DOI] [87]. Prognostic significance of peripheral blood monocyte and neutrophil counts in rheumatoid arthritis-associated interstitial lung disease.
Respiratory medicine [巻]182 [頁]106420 （2021年） [査読] 有
[DOI] [88]. Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study.
Scientific reports [巻]11 [号]1 [頁]9120 （2021年） [査読] 有
[DOI] [89]. Simple method for detecting idiopathic interstitial pneumonias by measuring vertical lung length on chest X-ray.
Scientific reports [巻]11 [号]1 [頁]7669 （2021年） [査読] 有
[DOI] [90]. Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes.
Journal of clinical medicine [巻]10 [号]7 （2021年） [査読] 有
[DOI] [91]. Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial.
Respirology (Carlton, Vic.) [巻]26 [号]4 [頁]370 -377 （2021年） [査読] 有
[DOI] [92]. Exposure to PM is a risk factor for acute exacerbation of surgically diagnosed idiopathic pulmonary fibrosis: a case-control study.
Respiratory research [巻]22 [号]1 [頁]80 （2021年） [査読] 有
[DOI] [93]. Conventional type 2 lung dendritic cells are potent inducers of follicular helper T cells in the asthmatic lung.
Allergology international : official journal of the Japanese Society of Allergology （2021年） [査読] 有
[DOI] [94]. Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival.
BMC pulmonary medicine [巻]21 [号]1 [頁]63 （2021年） [査読] 有
[DOI] [95]. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
Chest （2021年） [査読] 有
[DOI] [機関リポジトリ][96]. Subcutaneous injection of interferon gamma therapy could be useful for anti-IFN-γ autoantibody associated disseminated nontuberculous mycobacterial infection.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [巻]27 [号]2 [頁]373 -378 （2021年） [査読] 有
[DOI] [機関リポジトリ][97]. Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations.
Investigational new drugs [巻]39 [号]1 [頁]210 -216 （2021年） [査読] 有
[DOI] [機関リポジトリ][98]. Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease.
Scientific reports [巻]11 [号]1 [頁]1682 （2021年） [査読] 有
[DOI] [99]. Pneumothorax in Patients with Idiopathic Pleuroparenchymal Fibroelastosis: Incidence, Clinical Features, and Risk Factors.
Respiration; international review of thoracic diseases [巻]100 [号]1 [頁]19 -26 （2021年） [査読] 有
[DOI] [100]. Prophylactic granulocyte-colony stimulating factor in patients with lung neuroendocrine carcinoma receiving platinum agents plus etoposide.
Cancer treatment and research communications [巻]29 [頁]100493 （2021年） [査読] 有
[DOI] [101]. Palliative Care for Idiopathic Pulmonary Fibrosis Patients: Pulmonary Physicians' View.
Journal of pain and symptom management [巻]60 [号]5 [頁]933 -940 （2020年） [査読] 有
[DOI] [機関リポジトリ][102]. Influenza A virus enhances ciliary activity and mucociliary clearance via TLR3 in airway epithelium.
Respiratory research [巻]21 [号]1 [頁]282 （2020年） [査読] 有
[DOI] [103]. Development of a novel T cell-oriented vaccine using CTL/Th-hybrid epitope long peptide and biodegradable microparticles, against an intracellular bacterium.
Microbiology and immunology [巻]64 [号]10 [頁]666 -678 （2020年） [査読] 有
[DOI] [104]. Evaluation of Programmed Death Ligand 1 (PD-L1) Gene Amplification and Response to Nivolumab Monotherapy in Non-small Cell Lung Cancer.
JAMA network open [巻]3 [号]9 [頁]e2011818 （2020年） [査読] 有
[DOI] [105]. Intravoxel incoherent motion magnetic resonance imaging for predicting the long-term efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) [巻]143 [頁]47 -54 （2020年） [査読] 有
[DOI] [機関リポジトリ][106]. Pulse oximetric saturation to fraction of inspired oxygen (SpO/FIO) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease.
Therapeutic advances in respiratory disease [巻]14 [頁]1753466620906327 （2020年） [査読] 有
[DOI] [107]. Quantitative computed tomography measures of skeletal muscle mass in patients with idiopathic pulmonary fibrosis according to a multidisciplinary discussion diagnosis: A retrospective nationwide study in Japan.
Respiratory investigation [巻]58 [号]2 [頁]91 -101 （2020年） [査読] 有
[DOI] [108]. Author Correction: Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia.
Scientific reports [巻]10 [号]1 [頁]3324 （2020年） [査読] 有
[DOI] [109]. Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis.
Therapeutic advances in respiratory disease [巻]14 [頁]1753466620953783 （2020年） [査読] 有
[DOI] [110]. Pneumothorax in connective tissue disease-associated interstitial lung disease.
PloS one [巻]15 [号]7 [頁]e0235624 （2020年） [査読] 有
[DOI] [111]. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
Therapeutic advances in respiratory disease [巻]14 [頁]1753466620935774 （2020年） [査読] 有
[DOI] [112]. A GWAS approach identifies Dapp1 as a determinant of air pollution-induced airway hyperreactivity.
PLoS genetics [巻]15 [号]12 [頁]e1008528 （2019年） [査読] 有
[DOI] [113]. Simultaneous Occurrence of Sarcoidosis and Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis in a Patient with Lung Cancer.
Internal medicine (Tokyo, Japan) [巻]58 [号]22 [頁]3299 -3304 （2019年） [査読] 有
[DOI] [114]. Synchronous Occurrence of Bazex Syndrome and Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Patient with Lung Cancer.
Internal medicine (Tokyo, Japan) [巻]58 [号]22 [頁]3267 -3271 （2019年） [査読] 有
[DOI] [115]. Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone.
Respiratory investigation [巻]57 [号]6 [頁]552 -560 （2019年） [査読] 有
[DOI] [116]. Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases.
Respiratory medicine [巻]159 [頁]105811 （2019年） [査読] 有
[DOI] [117]. Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis.
Respirology (Carlton, Vic.) （2019年） [査読] 有
[DOI] [118]. Heterogeneity analysis of PD-L1 expression and copy number status in EBUS-TBNA biopsy specimens of non-small cell lung cancer: Comparative assessment of primary and metastatic sites.
Lung cancer (Amsterdam, Netherlands) [巻]134 [頁]202 -209 （2019年） [査読] 有
[DOI] [119]. Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
Respirology (Carlton, Vic.) [巻]24 [号]8 [頁]792 -798 （2019年） [査読] 有
[DOI] [120]. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
The Journal of rheumatology [巻]46 [号]8 [頁]935 -942 （2019年） [査読] 有
[DOI] [121]. Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Scientific reports [巻]9 [号]1 [頁]10484 （2019年） [査読] 有
[DOI] [122]. Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias.
Respiratory medicine [巻]154 [頁]102 -108 （2019年） [査読] 有
[DOI] [123]. Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting.
Cancer chemotherapy and pharmacology [巻]84 [号]1 [頁]147 -153 （2019年） [査読] 有
[DOI] [124]. Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
Investigational new drugs [巻]37 [号]3 [頁]531 -537 （2019年） [査読] 有
[DOI] [125]. Physiological and morphological differences of airways between COPD and asthma-COPD overlap.
Scientific reports [巻]9 [号]1 [頁]7818 （2019年） [査読] 有
[DOI] [126]. Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion.
The European respiratory journal [巻]53 [号]5 （2019年） [査読] 有
[DOI] [127]. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
The Journal of rheumatology [巻]46 [号]5 [頁]509 -517 （2019年） [査読] 有
[DOI] [128]. Clinical features of three-dimensional computed tomography-based radiologic phenotypes of chronic obstructive pulmonary disease.
International journal of chronic obstructive pulmonary disease [巻]14 [頁]1333 -1342 （2019年） [査読] 有
[DOI] [129]. Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial.
Journal of asthma and allergy [巻]12 [頁]253 -261 （2019年） [査読] 有
[DOI] [130]. Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease.
Respiratory medicine [巻]146 [頁]76 -80 （2019年） [査読] 有
[DOI] [131]. Differences in airway structural changes assessed by 3-dimensional computed tomography in asthma and asthma-chronic obstructive pulmonary disease overlap.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [巻]121 [号]6 [頁]704 -710.e1 （2018年） [査読] 有
[DOI] [132]. An Acquired Epidermal Growth Factor Receptor T790M Mutation after the Addition of Bevacizumab to Preceding Erlotinib Monotherapy in a Lung Cancer Patient with Leptomeningeal Metastases.
Internal medicine (Tokyo, Japan) [巻]57 [号]23 [頁]3423 -3427 （2018年） [査読] 有
[DOI] [133]. Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis.
Respiratory research [巻]19 [号]1 [頁]127 （2018年） [査読] 有
[DOI] [134]. Association of increased indoleamine 2, 3-dioxygenase with impaired natural killer cell activity in hemodialysis patients.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy [巻]18 [号]1 [頁]19 -23 （2014年） [査読] 有
[DOI] [135]. Mouse lung CD103+ and CD11bhigh dendritic cells preferentially induce distinct CD4+ T-cell responses.
American journal of respiratory cell and molecular biology [巻]46 [号]2 [頁]165 -72 （2012年） [査読] 有
[DOI] [136]. Relationship between an increased serum kynurenine/tryptophan ratio and atherosclerotic parameters in hemodialysis patients.
Hemodialysis international. International Symposium on Home Hemodialysis [巻]14 [号]4 [頁]418 -24 （2010年） [査読] 有
[DOI]